CN110157767A - 一种转移因子口服溶液生物活性测定方法 - Google Patents
一种转移因子口服溶液生物活性测定方法 Download PDFInfo
- Publication number
- CN110157767A CN110157767A CN201910314144.7A CN201910314144A CN110157767A CN 110157767 A CN110157767 A CN 110157767A CN 201910314144 A CN201910314144 A CN 201910314144A CN 110157767 A CN110157767 A CN 110157767A
- Authority
- CN
- China
- Prior art keywords
- liquid
- test sample
- oral solution
- transfer factor
- hank
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 45
- 108010074506 Transfer Factor Proteins 0.000 title claims abstract description 28
- 229940100688 oral solution Drugs 0.000 title claims abstract description 24
- 230000004071 biological effect Effects 0.000 title claims abstract description 13
- 238000012360 testing method Methods 0.000 claims abstract description 64
- 239000000725 suspension Substances 0.000 claims abstract description 55
- 210000000265 leukocyte Anatomy 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims description 66
- 238000002835 absorbance Methods 0.000 claims description 37
- 210000004027 cell Anatomy 0.000 claims description 34
- 239000013558 reference substance Substances 0.000 claims description 19
- 239000006228 supernatant Substances 0.000 claims description 18
- 210000001541 thymus gland Anatomy 0.000 claims description 16
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 14
- 238000011534 incubation Methods 0.000 claims description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 9
- 210000002751 lymph Anatomy 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 4
- 230000008033 biological extinction Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 210000004907 gland Anatomy 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 238000001514 detection method Methods 0.000 abstract description 11
- 238000005259 measurement Methods 0.000 abstract description 11
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract description 5
- 229910001425 magnesium ion Inorganic materials 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000427 antigen Substances 0.000 abstract description 2
- 102000036639 antigens Human genes 0.000 abstract description 2
- 108091007433 antigens Proteins 0.000 abstract description 2
- 238000011882 arthroplasty Methods 0.000 abstract description 2
- 239000000872 buffer Substances 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 210000004698 lymphocyte Anatomy 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 229960004424 carbon dioxide Drugs 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910314144.7A CN110157767A (zh) | 2019-04-18 | 2019-04-18 | 一种转移因子口服溶液生物活性测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910314144.7A CN110157767A (zh) | 2019-04-18 | 2019-04-18 | 一种转移因子口服溶液生物活性测定方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110157767A true CN110157767A (zh) | 2019-08-23 |
Family
ID=67639611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910314144.7A Pending CN110157767A (zh) | 2019-04-18 | 2019-04-18 | 一种转移因子口服溶液生物活性测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110157767A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0301992A2 (en) * | 1987-07-30 | 1989-02-01 | Centro Nacional De Biopreparados | Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor |
-
2019
- 2019-04-18 CN CN201910314144.7A patent/CN110157767A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0301992A2 (en) * | 1987-07-30 | 1989-02-01 | Centro Nacional De Biopreparados | Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor |
Non-Patent Citations (3)
Title |
---|
王灿等: "白细胞黏附抑制实验在核糖核酸药物免疫活力测定中的应用研究", 《中国药师》 * |
韩彩霞等: "抗乙肝特异性转移因子和核糖核酸体外生物活性的实验研究 Ⅲ.用白细胞移动抑制试验测活", 《中国生化药物杂志》 * |
黄青等: "转移因子脱E受体活力测定方法的优化及基于微量板-白细胞黏附抑制试验的新方法研究", 《中国药学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107076766B (zh) | 血液crp质控物及其质控方法 | |
CN106645726A (zh) | 一种循环肿瘤细胞快速检测试剂盒及其制备和应用方法 | |
CN109251886B (zh) | 一种提取脂肪组织来源外泌体的试剂盒及其提取方法和应用 | |
CN110157767A (zh) | 一种转移因子口服溶液生物活性测定方法 | |
SU1767433A1 (ru) | Способ определени инсулинорезистентности имунного генеза у больных сахарным диабетом I типа | |
CN109682875A (zh) | 用于肝细胞癌筛查的核酸电化学检测体系及检测方法 | |
CN102004151B (zh) | 禽流感病毒h9亚型血凝抑制抗原标准物质及制备方法 | |
CN101709329B (zh) | 卷烟烟气遗传毒性的体外细胞微核检测方法 | |
EP1842068A1 (en) | Use of multiparametric flow cytometry for the diagnosis, prognosis, and validation of immunotherapies in autoimmune, hematologic, and lymphoproliferative diseases | |
CN109459372A (zh) | 有核红细胞模拟粒子及其制备方法与应用 | |
US10724953B2 (en) | Method for evaluating phagocytic capacity and fluorescence measurement method | |
CN111172229B (zh) | 脾脏多肽制品的生物活性的测定方法 | |
Weiss et al. | Effects of echinocytosis on hermorrheologic values and exercise performance in horses | |
CN111521587A (zh) | 一种细胞内络氨酸磷酸化水平的检测方法 | |
CN115589988A (zh) | 一种检测乳清蛋白浓缩物对骨质疏松影响的方法 | |
CN107576624B (zh) | 一种唾液中皮质醇的检测方法 | |
CN101887059B (zh) | 嗜酸性粒细胞模拟物、制备方法及全血质控物 | |
RU2225446C2 (ru) | Способ определения концентрации вирусов в жидком биологическом материале и устройство для его осуществления | |
CN109521201A (zh) | 一种用于便携式血糖仪的人源全血基质质控品 | |
CN108754024A (zh) | 一种eb病毒dna的定量检测方法 | |
Ali et al. | Development of the determination of ABO and Rh systems of blood group typing using acousto-optical technique | |
WO2024078647A2 (zh) | 一种神经组织单细胞悬液的制备方法 | |
CN111781042B (zh) | 一种附红细胞体检测试剂盒及样品处理方法 | |
SU1712875A1 (ru) | Способ дифференциальной диагностики хронического обструктивного бронхита и аллергической бронхиальной астмы | |
SU1116394A1 (ru) | Способ определени литической активности веществ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xue Meiling Inventor after: Guo Weizhen Inventor after: Yang Mengcong Inventor after: Liu Peng Inventor after: Chen Tonghua Inventor before: Chen Tonghua Inventor before: Xue Meiling Inventor before: Guo Weizhen Inventor before: Yang Mengcong Inventor before: Liu Peng |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190823 |